SSA
NVAX icon

Schonfeld Strategic Advisors’s Novavax NVAX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
194,567
+104,654
+116% +$938K 0.01% 1111
2026
Q1 		$732K Sell
89,913
-20,122
-18% -$182K 0.01% 1232
2025
Q4 		$739K Buy
110,035
+52,089
+90% +$393K ﹤0.01% 1247
2025
Q3 		$502K Buy
+57,946
New +$451K ﹤0.01% 1688
2025
Q1 		– Sell
-27,283
Closed -$219K – 2413
2024
Q4 		$219K Buy
27,283
+8,454
+45% +$81.5K ﹤0.01% 1736
2024
Q3 		$238K Sell
18,829
-4,072
-18% -$52.6K ﹤0.01% 1753
2024
Q2 		$290K Buy
+22,901
New +$230K ﹤0.01% 1700
2024
Q1 		– Sell
-10,395
Closed -$49.9K – 2292
2023
Q4 		$49.9K Sell
10,395
-73,346
-88% -$449K ﹤0.01% 1670
2023
Q3 		$606K Buy
+83,741
New +$669K ﹤0.01% 1157
2023
Q1 		– Sell
-44,500
Closed -$457K – 2468
2022
Q4 		$457K Sell
44,500
-158,959
-78% -$2.81M ﹤0.01% 1574
2022
Q3 		$3.7M Buy
203,459
+141,731
+230% +$6.14M 0.03% 633
2022
Q2 		$3.17M Buy
61,728
+34,546
+127% +$1.79M 0.03% 606
2022
Q1 		$2M Buy
27,182
+20,608
+313% +$1.84M 0.02% 739
2021
Q4 		$941K Buy
+6,574
New +$1.13M 0.01% 975
2021
Q3 		– Sell
-12,900
Closed -$2.74M – 2370
2021
Q2 		$2.74M Buy
+12,900
New +$2.36M 0.03% 618
2019
Q2 		– Sell
-985
Closed -$11K – 1175
2019
Q1 		$11K Sell
985
-22,040
-96% -$696K ﹤0.01% 1007
2018
Q4 		$847K Buy
+23,025
New +$892K 0.03% 516

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Schonfeld Strategic Advisors's NVAX Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Novavax (NVAX) stake by 116% in Q2 2026, buying an estimated $938K and bringing the position to 194,567 shares worth $1.83M. The position accounts for 0.01% of the portfolio, ranked #1111.

Schonfeld Strategic Advisors first reported a position in NVAX in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.7M in Q3 2022. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Schonfeld Strategic Advisors held 194,567 shares of Novavax worth $1.83M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 104,654 Novavax shares in Q2 2026, an estimated $938K.
  • Novavax made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1111 holding.
  • Schonfeld Strategic Advisors first reported a position in Novavax in Q4 2018 and has held it in 17 quarters since.
  • Schonfeld Strategic Advisors's Novavax position peaked at $3.7M in Q3 2022.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.